Title
Antibacterial, antifungal and antileishmanial activities of indolone-N-oxide derivatives
Date Issued
01 October 2012
Access level
open access
Resource Type
journal article
Author(s)
Ibrahim H.
Furiga A.
Najahi E.
Pigasse Hénocq C.
Nallet J.P.
Roques C.
Aubouy A.
Constant P.
Daffé M.
Nepveu F.
Toulouse University III
Abstract
An alarming increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds. Indolone-N-oxides (INODs) possess a redox pharmacophore with promising, recently established, antimalarial activities. In this study, the anti-infectious properties of a series of INODs were investigated. The antibacterial activity was evaluated against five bacterial strains Gram-positive (Staphylococcus aureus, Enterococcus hirae), Gram-negative (Pseudomonas aeruginosa, Escherichia coli) and acid-fast (Mycobacterium tuberculosis). The antifungal activity was assessed using two fungal strains (Aspergillus niger, Candida albicans). The antileishmanial activity was tested against two leishmanial strains, axenically-cultured amastigote (Leishmania infantum, Leishmania amazonensis). The pharmacological activities are discussed as a function of structural and lipophilic characteristics. The Gram-positive bacterial strain E. hirae was found to be the most sensitive strain, whereas the Gram-negative E. coli was resistant to this family of compounds. One compound (64) was more potent than nalidixic acid against E. hirae, whereas another one (52) was equipotent as clotrimazole against C. albicans. INODs were microbe -cidal rather than -static. INODs showed good antitubercular activity in the low micromolar range (similar to ciprofloxacin). In addition, INOD-antiprotozoal potencies were confirmed against the leishmania parasite. INODs showed a broad spectrum of antimicrobial activity and offer a promising anti-infectious prototype worthy of being developed. © 2012 Japan Antibiotics Research Association All rights reserved.
Start page
499
End page
504
Volume
65
Issue
10
Language
English
OCDE Knowledge area
Biología celular, Microbiología
Subjects
Scopus EID
2-s2.0-84868125592
PubMed ID
Source
Journal of Antibiotics
ISSN of the container
00218820
Sponsor(s)
This work was supported by the European Union (Redox antimalarial drug discovery, Read-Up, FP6-2004-LSH-2004-2.3.0-7, Strep n1 018602). Thanks are due to the Fondation pour la Recherche Médicale for financial support. We wish to thank E Pelissou and E Augugliaro for technical assistance.
Sources of information:
Directorio de Producción Científica
Scopus